Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition — Santiago Ropero (2006) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
Shared by
Manel Esteller
University of Barcelona
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
Article
2006
en
Authors
+14 more
SR
Santiago Ropero
MF
Mario F. Fraga
EB
Esteban Ballestar
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2008
Transforming pathways unleashed by a HDAC2 mutation in human cancer
Santiago Ropero
,
Esteban Ballestar
,
Miguel Alaminos
,
Diego Arango
,
Simó Schwartz
,
Manel Esteller
Article
2004
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase
Peter J Barnes
,
Kazuhiro Ito
,
Ian M. Adcock
Article
2013
AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma
Wanglai Hu
,
Lei Jin
,
C C Jiang
,
Georgina V. Long
,
Richard A Scolyer
,
Qingang Wu
,
Xu Dong Zhang
,
Yide Mei
,
Mian Wu
Article
2003
Snail Mediates E-Cadherin Repression by the Recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex
Héctor Peinado
,
Esteban Ballestar
,
Manel Esteller
,
Amparo Cano
Article
2008
Recruitment of CREB1 and Histone Deacetylase 2 (HDAC2) to the Mouse Ltbp-1 Promoter Regulates its Constitutive Expression in a Dioxin Receptor-dependent Manner
Áurea Gómez-Durán
,
Esteban Ballestar
,
José María Carvajal-González
,
Jennifer Marlowe
,
Alvaro Puga
,
Manel Esteller
,
Pedro M. Fernández‐Salguero
Discussion(0)
No comments yet. Be the first to comment.